Abstracts

Citation

Denise Jacobson, Elizabeth M. Lindsey, B.S.N., Grace M. Aldrovandi, MD, Barbara E. Heckman, B.S., Amanda Zadzilka, B.S., John ( Jack ) Moye, Jr., M.D., Peggy R. Borum, Ph.D., Dana S. Hardin, M.D., Kathleen Mulligan, Ph.D. Total body and spine bone mineral density across Tanner stages in vertically HIV-infected compared to uninfected children and youth: Preliminary results of PACTG1045. Presented at: International Workshop on Drug Reations and Lipodystrop.

Citation

Lujan-Zilbermann J, Williams PL, Siberry GK, Read JS, Jean-Philippe P, Heckman BE, Meredith Warshaw, M.A., Sharon Appelbaum Nachman, M.D. Safety of quadrivalent meningococcal conjugate vaccine (MCV4) in HIV-infected youth. Presented at: 48th Intersci Conf on Antimicrobial Agents & Chemotherapy; 2008 Oct 26.

Citation

Sue Kim, Shabir A. Madhi, M.D., Shabir A. Madhi, M.D., Sharon Appelbaum Nachman, M.D., Avy Violari, M.D., Charles Debeaux Mitchell, M.D., Mark F. Cotton, MMED, Ph.D., MB ChB, Raziya Bobat, M.D., Patrick Jean-Philippe, M.D., George D. McSherry, M.D., George D. McSherry, M.D. Lack of Efficacy of Primary Isoniazid (INH) Prophylaxis in Increasing Tuberculosis (TB) Free Survival in HIV-infected (HIV+) South African Children. Presented at: 48th Intersci Conf on Antimicrobial Agents & Chemotherapy.

Citation

Jennifer J. Kiser, Pharm.D., R Zhu, Sharon Appelbaum Nachman, M.D., Carol K. Mitchell, George D. McSherry, M.D., Shabir A. Madhi, M.D., Mark F. Cotton, MMED, Ph.D., MB ChB, Raziya Bobat, M.D., Soyeon Kim, Ph.D., Heiner Seifart, Cedric John Werely, D Z D'Argenio, Courtney V. Fletcher, Pharm.D. Pharmacokinetics (PK) and genetics (PG) of isoniazid (INH) in South African HIV-exposed infants. Presented at: 48th Intersci Conf on Antimicrobial Agents & Chemotherapy.

Citation

Heather Jaspan, M.D., F.A.A.P., Ph.D., D. Mark, N. Soka, L. Myer, Keren Middelkoop, A. J. Flisher, W. Christopher Mathews, M.D., M.S.P.H., Linda-Gail Bekker, MB ChB, D.C.H., Ph.D. Retention, sexual risk, and behaviour change in a cohort of HIV-negative South African adolescents. Presented at: AIDS Vaccine 2008 International Conference.

Citation

Brenda Asiimwe-Kateera, Kenneth Kintu, Sheryl L. Zwerski, M.S.N, Molly Swenson, Molly Swenson, Lynda Emel, John ( Jack ) Moye, Jr., M.D., Mary Glenn Fowler, M.D., M.P.H., Philippa Musoke, MB ChB, Lynn Baglyos, M.S.N, Laura A. Guay, M.D. Participant Retention and Safety of ALVAC-HIV vCP1521 in Infants Born to HIV-1 Infected Women in Uganda (HPTN 027). Presented at: Annual International Meeting of the Institute of Human Virol.

Citation

Kunjal Patel, D.Sc., M.P.H., Sue X. Ming, Paige L. Williams, Ph.D., Kevin R. Robertson, Ph.D., James M. Oleske, M.D., George Seage, III, Sc.D., M.P.H. Impact of highly active antiretroviral therapy on the incidence of HIV-encephalopathy among perinatally-infected children and adolescents. Presented at: XVII International AIDS Conference.

Citation

Paige L. Williams, Ph.D., Miguel Marino, Kathleen Malee, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P. Neurodevelopmental status and prenatal antiretroviral exposure in HIV-exposed uninfected infants. Presented at: XVII International AIDS Conference.

Citation

Juan Carlos Salazar, M.D., M.P.H., Pedro E. Cahn, M.D., Carlo Giaquinto, M.D., Ram Yogev, M.D., Jaromir Mikl, Ante Jelaska, M.D. Efficacy and safety profile of APTIVUS oral solution or capsules co-administered with low dose ritonavir (APTIVUS/r) in treatment experienced children and teenagers after two years of treatment (Phase I/IIa study). Presented at: XVII International AIDS Conference.

Citation

Lynne M. Mofenson, M.D., F.A.A.P., Paige L. Williams, Ph.D., Michael T. Brady, M.D., Russell B. Van Dyke, M.D., Wayne M. Dankner, M.D., James M. Oleske, M.D. Trends in mortality in HIV-infected children in the United States - 1994-2006. Presented at: XVII International AIDS Conference.